Target intelligence / Profile preview

Immunoglobulin heavy variable 1-18 (IGHV1-18)

Target
IGHV1-18
Molecular classification
Variable region of immunoglobulin heavy chain, Immunoglobulin gene family, Antigen-binding protein domain (Immunoglobulin variable domain)
01

Overview

Immunoglobulin heavy variable 1-18 (IGHV1-18) is a gene segment that encodes the variable region of the heavy chain of immunoglobulins (antibodies)[2][4]. The variable region is responsible for antigen binding and is generated through V(D)J recombination, which ensures the diversity of antibodies in the adaptive immune system[2][3]. This segment is part of the immunoglobulin heavy chain locus, which contains multiple variable, diversity, joining, and constant regions, with the variable regions determining the specificity for antigen recognition[1][3]. IGHV1-18 is therefore crucial for the adaptive immune response but does not act as a traditional therapeutic target (such as a receptor, enzyme, or transporter)[2][4]. Variation in IGHV genes contributes to the diversity of antibody responses and may indirectly influence susceptibility to immune-related diseases, but IGHV1-18 is not a direct disease driver or therapeutic receptor[2][3][5].

Other names
Immunoglobulin heavy variable 1-18IGHV1-18IGHV118HV118
02

Biological functions

Antigen recognitionAdaptive immune responseB cell receptor diversity
03

Disease associations

Other (variation in IGHV genes may be linked to immune-related disease susceptibility, but IGHV1-18 itself is not a direct disease target)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 1-18 (IGHV1-18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 1-18 (IGHV1-18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call